June 13, 2024 / 10:15 IST
Reported Consolidated quarterly numbers for ANG Lifesciences India are:Net Sales at Rs 37.84 crore in March 2024 down 4.05% from Rs. 39.44 crore in March 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 3.65 crore in March 2024 up 20.88% from Rs. 4.61 crore in March 2023.
EBITDA stands at Rs. 3.55 crore in March 2024 up 441.35% from Rs. 1.04 crore in March 2023.
ANG Lifescience shares closed at 53.87 on June 12, 2024 (BSE) and has given -18.08% returns over the last 6 months and -23.50% over the last 12 months.
| ANG Lifesciences India | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 37.84 | 18.55 | 39.44 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 37.84 | 18.55 | 39.44 | | EXPENDITURE | | Consumption of Raw Materials | 33.06 | 13.58 | 38.71 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -7.99 | -2.00 | -2.00 | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.15 | 4.49 | 5.85 | | Depreciation | 2.05 | 1.91 | 3.03 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 5.27 | 4.39 | 7.16 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 1.31 | -3.82 | -13.31 | | Other Income | 0.19 | -0.03 | 9.23 | | P/L Before Int., Excpt. Items & Tax | 1.50 | -3.85 | -4.07 | | Interest | 3.84 | 2.51 | 1.65 | | P/L Before Exceptional Items & Tax | -2.34 | -6.37 | -5.73 | | Exceptional Items | -1.74 | -- | -- | | P/L Before Tax | -4.08 | -6.37 | -5.73 | | Tax | -0.43 | -0.44 | -1.12 | | P/L After Tax from Ordinary Activities | -3.65 | -5.93 | -4.61 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -3.65 | -5.93 | -4.61 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -3.65 | -5.93 | -4.61 | | Equity Share Capital | 13.06 | 13.06 | 13.06 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.75 | -4.53 | -3.63 | | Diluted EPS | -2.75 | -4.53 | -3.63 | | EPS After Extra Ordinary | | Basic EPS | -2.75 | -4.53 | -3.63 | | Diluted EPS | -2.75 | -4.53 | -3.63 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
